ArticleJournal of ophthalmology2026
Efficacy of Ophthalmic Viscosurgical Device-Assisted Vitrectomy for Membrane Removal in Patients With Complex Proliferative Diabetic Retinopathy.
Article in Journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Efficacy of Ophthalmic Viscosurgical Device-Assisted Vitrectomy for Membrane Removal in Patients With Complex Proliferative Diabetic Retinopathy.Journal of ophthalmology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: To assess the application of an ophthalmic viscosurgical device (OVD) for stripping proliferative membranes during vitrectomy in patients with complex proliferative diabetic retinopathy (PDR). Methods: This was a prospective cohort study that enrolled 28 patients (30 eyes) diagnosed with complex PDR at the Affiliated Eye Hospital of Nanjing Medical University. The patients were randomly divided into two groups based on different surgical procedures: The patients who received vitrectomy combined with OVD-assisted internal limiting membrane peeling were assigned to Group A (15 eyes of 13 patients), while Group B patients (15 eyes of 15 patients) underwent vitrectomy without OVD-assisted internal limiting membrane peeling. The primary outcomes measured included intraoperative bleeding, operation duration, electrocoagulation for hemostasis, occurrence of iatrogenic retinal holes, postoperative best-corrected visual acuity (BCVA), and complications such as recurrent retinal detachment and vitreous hemorrhage. Results: Compared with the mean preoperative BCVA, the mean postoperative BCVA at the last follow-up improved significantly in both groups (all Conclusion: Our study demonstrates a new application of OVD in proliferative membrane removal during vitrectomy, particularly in patients with PDR characterized by strong adhesions and complex structures. This method offers a potentially safer and more effective option for treating patients with PDR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.